v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows From Operating Activities    
Net loss $ (6,186) $ (7,653)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,571 2,943
Interest accretion expense 85 270
Bad debt recovery (140)
Mark to market on warrants (68) 209
Amortization of deferred financing fees 31 88
Interest - note payable 220
Stock-based compensation 613 777
ESPP expense 46 60
Change in fair value of note payable (160)
Change in fair value of contingent consideration (311) (57)
Gain on DiamiR transaction   (235)
Other gains and expenses, net (2)
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (288) 841
Increase in other current assets (3) (548)
Increase (decrease) in accounts payable 794 (2,032)
Increase (decrease) in accrued salaries and bonus 278 (719)
Decrease in accrued liabilities (646) (802)
Increase (decrease) in long-term liabilities 72 (45)
Net cash used in operating activities (4,172) (6,825)
Cash Flows From Investing Activity    
Purchase of property and equipment (86) (48)
Sale of property and equipment 39
Net cash used in investing activities (86) (9)
Cash Flows From Financing Activities    
Issuance of common stock, net of expenses 59 108
Loan proceeds - related parties 7,500
Financing fees - related party (105)
Proceeds from convertible debt 2,000
Borrowings on line of credit 1,000
Net cash provided by financing activities 3,059 7,503
Net (decrease) increase in cash, cash equivalents and restricted cash (1,199) 669
Cash, cash equivalents and restricted cash – beginning 3,314 3,372
Cash, cash equivalents and restricted cash – ending $ 2,115 $ 4,041

Source